Business Description
Ionis Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US4622221004
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.6 | |||||
Equity-to-Asset | 0.13 | |||||
Debt-to-Equity | 3.76 | |||||
Debt-to-EBITDA | -6.16 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.45 | |||||
Beneish M-Score | -0.66 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.7 | |||||
3-Year EBITDA Growth Rate | -27.4 | |||||
3-Year EPS without NRI Growth Rate | 2.8 | |||||
3-Year FCF Growth Rate | -298.6 | |||||
3-Year Book Growth Rate | -20.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.61 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 22.03 | |||||
12-1 Month Momentum % | 2.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.9 | |||||
Quick Ratio | 5.83 | |||||
Cash Ratio | 5.2 | |||||
Days Inventory | 989.77 | |||||
Days Payable | 672.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -3.69 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.84 | |||||
Operating Margin % | -44.91 | |||||
Net Margin % | -46.5 | |||||
FCF Margin % | -43.44 | |||||
ROE % | -83.63 | |||||
ROA % | -12.79 | |||||
ROIC % | -73.29 | |||||
ROC (Joel Greenblatt) % | -101.18 | |||||
ROCE % | -10.25 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.75 | |||||
PB Ratio | 15.89 | |||||
Price-to-Tangible-Book | 15.89 | |||||
EV-to-EBIT | -20.62 | |||||
EV-to-Forward-EBIT | -9.53 | |||||
EV-to-EBITDA | -22.59 | |||||
EV-to-Forward-EBITDA | -9.82 | |||||
EV-to-Revenue | 6.77 | |||||
EV-to-Forward-Revenue | 8.76 | |||||
EV-to-FCF | -15.88 | |||||
Price-to-Projected-FCF | 8.22 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Net-Current-Asset-Value | 157.62 | |||||
Earnings Yield (Greenblatt) % | -4.85 | |||||
FCF Yield % | -5.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ionis Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 13,723.434 | ||
EPS (TTM) (MXN) | -45.201 | ||
Beta | -0.34 | ||
Volatility % | 28.34 | ||
14-Day RSI | 100 | ||
14-Day ATR (MXN) | 0.228517 | ||
20-Day SMA (MXN) | 900 | ||
12-1 Month Momentum % | 2.59 | ||
52-Week Range (MXN) | 737.51 - 900 | ||
Shares Outstanding (Mil) | 145.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ionis Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ionis Pharmaceuticals Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Ionis Pharmaceuticals Inc Frequently Asked Questions
What is Ionis Pharmaceuticals Inc(MEX:IONS)'s stock price today?
When is next earnings date of Ionis Pharmaceuticals Inc(MEX:IONS)?
Does Ionis Pharmaceuticals Inc(MEX:IONS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |